RBMS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.642800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.414400E-01
Normal-vs-Stage2
9.502400E-01
Normal-vs-Stage3
4.601600E-01
Normal-vs-Stage4
7.167200E-01
Stage1-vs-Stage2
1.768040E-01
Stage1-vs-Stage3
6.296600E-01
Stage1-vs-Stage4
1.354440E-01
Stage2-vs-Stage3
5.034200E-01
Stage2-vs-Stage4
6.197400E-01
Stage3-vs-Stage4
3.121600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.411000E-01
Normal-vs-AfricanAmerican
8.018600E-01
Normal-vs-Asian
4.518200E-01
Caucasian-vs-AfricanAmerican
5.045200E-01
Caucasian-vs-Asian
2.673600E-01
AfricanAmerican-vs-Asian
2.262000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.742000E-01
Normal-vs-Female
9.999800E-01
Male-vs-Female
2.504000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.729200E-01
Normal-vs-Age(41-60Yrs)
6.749400E-01
Normal-vs-Age(61-80Yrs)
6.969200E-01
Normal-vs-Age(81-100Yrs)
3.405600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.830000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.911000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.615400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.939800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.187600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.562600E-01
Normal-vs-Daily Drinker
4.606400E-01
Normal-vs-Weekly Drinker
9.573600E-01
Normal-vs-Occasional Drinker
9.310000E-01
Normal-vs-Social Drinker
9.600800E-01
Non Drinker-vs-Daily Drinker
9.113000E-01
Non Drinker-vs-Weekly Drinker
2.094800E-01
Non Drinker-vs-Occasional Drinker
1.192640E-01
Non Drinker-vs-Social Drinker
2.911200E-01
Daily Drinker-vs-Weekly Drinker
2.477600E-01
Daily Drinker-vs-Occasional Drinker
1.575790E-01
Daily Drinker-vs-Social Drinker
3.540400E-01
Weekly Drinker-vs-Occasional Drinker
8.112200E-01
Weekly Drinker-vs-Social Drinker
9.796400E-01
Occasional Drinker-vs-Social Drinker
8.191000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.329400E-01
Normal-vs-Grade 2
1.246580E-01
Normal-vs-Grade 3
1.911970E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.636070E-02
Grade 1-vs-Grade 3
3.096200E-02
Grade 1-vs-Grade 4
6.329400E-01
Grade 2-vs-Grade 3
8.178600E-01
Grade 2-vs-Grade 4
1.246580E-01
Grade 3-vs-Grade 4
1.911970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.390600E-01
Normal-vs-NonDiabetic
7.668200E-01
Diabetic-vs-NonDiabetic
8.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.649600E-01
Normal-vs-NoPancreatitis
7.785400E-01
Pancreatitis-vs-NoPancreatitis
6.798200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.160200E-01
Normal-vs-N1
9.739200E-01
N0-vs-N1
1.827830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.154600E-01
Normal-vs-TP53-NonMutant
3.914800E-01
TP53-Mutant-vs-TP53-NonMutant
7.897000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
